OptiBiotix is an early-stage, revenue-generating life sciences business with novel IP surrounding the modulation of the human microbiome. Its technology is focused on tackling worldwide health issues (e.g. obesity, diabetes, high cholesterol and microbial infections), exploiting these large market segments via the c.£200bn functional foods market by partnering with food, health, wellbeing and pharmaceutical companies that have established routes to market. With the microbiome fast becom
24 Jan 2017
Go with your gut
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Go with your gut
OptiBiotix Health PLC (OPTI:LON) | 18.0 0 0.0% | Mkt Cap: 17.6m
- Published:
24 Jan 2017 -
Author:
Mark Brewer | Cavendish Research -
Pages:
28
OptiBiotix is an early-stage, revenue-generating life sciences business with novel IP surrounding the modulation of the human microbiome. Its technology is focused on tackling worldwide health issues (e.g. obesity, diabetes, high cholesterol and microbial infections), exploiting these large market segments via the c.£200bn functional foods market by partnering with food, health, wellbeing and pharmaceutical companies that have established routes to market. With the microbiome fast becom